Life Sciences


Community Blog

Use the blog to discuss and comment on the latest industry insights provided by our analyst experts.

Share this:

Latest posts

FDA Promotes Transparency and Patient Engagement with New Website

The FDA Patient Network On April 23, FDA Commissioner Margaret Hamburg, M.D. announced the launch of The FDA Patient Network website in a blog post on the FDA site. Hamburg states that the “FDA Patient Network website is an interactive tool for educating patients, patient advocates, and consumers on how their medications—both prescription and over...

Merck and Pfizer - Strange bedfellows?

In a surprising announcement made yesterday, Merck and Pfizer are teaming up to commercialize Pfizer’s SGLT2 inhibitor ertugliflozin for diabetes.  This announcement took the pharma world by surprise, especially since Merck in particular is not known for forming partnerships with other big pharmas.  Typically these partnerships leverage the individ...

Biosimilars: blockbuster or lackluster?

In follow up to my last blog, as a result of the Omontys recall, Affymax has resorted to a 75 percent reduction in staff in order to stay afloat, and may even be forced into bankruptcy. Although Affymax is a small company who is reliant on this single product, they were forecast to earn peek sales from Omontys in 2018 of approximately $484 million ...

More Calls to End Fee for Service: A Look at Recommendations from the National Commission on Physician Payment Reform

“Our nation cannot control runaway medical spending without fundamentally changing how physicians are paid.” The National Commission on Physician Payment Reform, March 2013 In March 2012, the Society of General Internal Medicine (SGIM) assembled an expert commission to look at ways of changing physician reimbursement in order to improve patient ...

Could the U.S. biosimilars market suffer from a recent branded biologic's misfortune?

Affymax’s and Takeda’s biologic drug for anemia, Omontys, is the latest victim of the discovery of serious adverse events in the post-marketing setting. Less than a year after the FDA granted marketing approval, reports of serious anaphylactic reactions, three of which were fatal, prompted the companies to recall the drug. Omontys is a similar drug...

Accountable Care Movement Taking Hold Throughout the Market, Surprising Many Industry Thought Leaders

The November 2012 issue of Health Affairs takes a look at the rapidly emerging market for Accountable Care Organizations (ACOs). Among several articles about ACO’s in this month’s issue is an informative piece by Harris Meyer that provides a good overview of where things towards the end of 2012. Meyer, H. Many Accountable Care Organizations Are N...

Connected Health: Global Perspectives on Identifying and Establishing Your Markets

Frost & Sullivan Growth Opportunity Briefings in Asia Pacific (Tokyo, Seoul, Singapore). Covered by the Korean media in Seoul, Korea. Speakers: Daniel Ruppar, Ajay Sunder from Frost & Sullivan giving combined perspectives from our Healthcare and Information/Communication Technologies groups on this important area of cross-industry convergence and h...

Access, Action, and Attitudes: ONC Accelerates Efforts to Engage Consumers and Patients with Health IT

The Seventh Annual National Health IT Week, sponsored by the Health Information Management Systems Society (HIMSS), the Institute for e-Health Policy, and the College of Healthcare Information Management Executives (CHIME), took place during the week of September 10, 2012. National Health IT Week features a variety of live and online events hosted ...

A New Era in Health Data Analytics: The Key to Health Care Transformation

Health IT Needed to Transform Patient Care The provision of health services is an exceptionally data-intensive endeavor. Of course, other industries are also very data-intensive but the health care industry has notably lagged in making use of advanced information technology (IT) solutions to manage and process vast troves of data. Health care data...

U.S. Supreme Court Upholds the Affordable Care Act; Health IT Market Will Accelerate Across the Board

Summary of Supreme Court Ruling On June 28, 2012, the United States Supreme Court, in a 5-4 decision, found that the Patient Protection and Affordable Care Act’s individual mandate is a tax and thus allowable under Congress’ constitutional power to levy taxes. Under the law, most people, save those who quality for exceptions based on financial or ...

Hospital Merger Mania Continues Unabated Signaling Permanent Market Shift

The New York Times recently reported news of a proposed merger between two of New York City’s largest hospital systems—New York University’s Langone Medical Center, which has 1,069 beds, and Continuum Health Partners, which includes Beth Israel and two campuses of St. Luke’s-Roosevelt and has a total of 2,180 beds. (New York Hospitals Look to Combi...

Progress and Continuing Challenges in the Adoption of Electronic Health Records

      The CMS EHR Incentive Programs The adoption of health information technology like electronic health records (EHRs) and health information exchange (HIE) has been a top priority of the United States federal government since the administration of George W. Bush. The Obama administration has accelerated the push towards health IT with approx...

Tools

Blog Archive


Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..